# Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia

> **NCT02864654** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation** · enrollment: 9 (estimated)

## Conditions studied

- Critical Limb Ischemia
- Arteriosclerosis Obliterans
- Peripheral Arterial Disease
- Thromboangiitis Obliterans
- Diabetic Angiopathies

## Interventions

- **PROCEDURE:** ADRC injection
- **OTHER:** ADRC isolation
- **PROCEDURE:** Liposuction

## Key facts

- **NCT ID:** NCT02864654
- **Lead sponsor:** Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07
- **Primary completion:** 2017-08
- **Final completion:** 2018-07
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2016-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02864654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02864654, "Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02864654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*